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Introduction
Congestive heart failure (CHF) means the heart is unable to maintain sufficient cardiac output to meet the demand of the body. 1 It is a common presentation to the emergency department (ED). Most patients with CHF need hospitalisation to medical wards for treatment. As reported in older studies, 2, 3 clinical parameters such as New York Heart Association (NYHA) functional class and presence of peripheral oedema were predictors of length of hospitalisation. However, the length of hospitalisation still varies even among patients with similar clinical parameters. More precise method with better predictive value for length of hospitalisation is needed in order to identify a group of patients with anticipated short hospital stay to be managed in the Short Stay Ward of the ED. Admission of these patients to medical wards can be avoided. More precise risk stratification can help to develop measures to alleviate the stringent bed situation in medical wards.
Previous studies found that B-type natriuretic peptide (BNP) level was elevated in patients with severe CHF. 4 The BNP level also had a predictive value on the length of hospitalisation in patients with severe CHF. In one Keywords: Brain natriuretic peptide, heart failure, length of stay, point-of-care systems study, patients with baseline BNP level >1500 pg/ml had almost twice the length of stay as patients with BNP <500 pg/ml (10.1 vs. 5.7 days). 4 In another study, it was shown that patients with high admission BNP level would have a longer hospital stay compared with patients with lower BNP level and the result was statistically significant. 5 It was also shown that patients with poor NYHA functional class during emergency admission had longer length of hospitalisation and higher mortality. 2 In another study on factors influencing the length of stay of CHF patients, a longer length of stay was associated with the presence of oedema at admission, duration of treatment with intravenous diuretics, development of renal impairment, concurrent respiratory problem, and social problems requiring intervention. 3 The aim of this study was to assess the predictive value of BNP level measured at the ED on the length of hospital stay (LOS) in patients with congestive heart failure. In addition, we would like to compare whether BNP level could be a better predictor of LOS than clinical parameters and to establish a cut-off point of BNP level which could differentiate CHF patients with short hospital stay from the whole population of CHF patients.
Method
The study was conducted in the Accident and Emergency Department of Queen Elizabeth Hospital from September 2008 to August 2009. Patients aged 18 or above attending the ED with clinical features compatible with CHF were included in the study. Exclusion criteria included: (1) new onset CHF which required in-patient management and workup, (2) patients with known history of respiratory diseases or renal disease which could mimic CHF, (3) patients with concurrent acute myocardial infarction which might cause elevation of BNP level even not in a state of heart failure. Patients with acute pulmonary oedema were also included in the study. Patients would be excluded, after recruitment, if they were subsequently found to suffer from myocardial infarction as evidenced by either electrocardiogram change or elevated cardiac enzymes after admission. Pregnant patients and patients who could not give valid consent were also excluded.
The primary outcome was to study the predictive value of BNP level on LOS. The LOS was defined as the time duration between the time of registration at our ED and the final discharge from hospital. The duration of hospital stay in convalescent hospital after treatment in acute medical wards was also included in the calculation of LOS. The secondary outcomes included studying the predictive value of BNP level on readmission for CHF within 6 months and the 6-month mortality, the predictive value of various clinical features versus LOS, and mean LOS of patients with BNP level less and greater than different cut-off points of BNP levels. The predictive value of BNP level on LOS was expressed in correlation coefficient. Despite extensive literature search, no information on correlation coefficient of BNP level versus LOS had been reported. 6 The sample size of this study could only be calculated basing on an assumption that the estimated correlation coefficient would equal to 0.3, alpha=0.05 and beta= 0.2. The estimated sample size would be 85 by using a formula based on the parameters as stated.
When an eligible CHF patient was identified by medical staff of the ED, the patient would be asked to be recruited into the study. The case doctor would obtain consent for the study. After consent was obtained, an extra quantity of blood (one millilitre) would be taken from the patient during blood specimen collection for investigation as a part of the standard care for CHF patients. The extra blood sample was used for measuring BNP level with a point-of-care test device (Biosite Triage Meter and Triage Profiler S.O.B. panel, Biosite Diagnostics, San Diego, California, USA) by phlebotomists. The BNP level and clinical features would be recorded on a data sheet. Patient's management would not be altered by the BNP level. Both caregivers and patients were blinded to the BNP level. The decision for in-patient discharge was solely based on clinical improvement rather than the admission BNP level. BNP measurement was not available after hospital admission. The LOS, 6-month readmission and mortality were retrieved from the Clinical Management System (CMS) of the hospital. The data was analysed with Statistical Package for Social Sciences Version 17 (SPSS 17). Chi-square test was used to test the association of non-parametric data, Student's t test was used to test the association of parametric data, and Pearson's correlations were used to test the association of BNP level and other clinical parameters with the LOS, 6 month readmission and mortality rate.
Recruitment of patients was based on consecutive convenience sampling. Some eligible CHF patients might not be recruited if the department was prohibitively busy. This study was approved by the Research Ethics Committee (Kowloon Central/Kowloon East) of the Hospital Authority.
Results
Of the 112 patients initially recruited into this study, 20 succumbed during hospitalisation. The remaining 92 patients had enough data for analysis with regard to the primary and secondary outcomes. For those who succumbed during hospitalisation, analysis of correlation of BNP level versus 6-month mortality was performed. No patient was excluded from the study because of myocardial infarction. The outline of the subject enrolment was illustrated in Figure 1 . All survived patients had regular follow up. Clinical events, including readmission and mortality within 6 months, could be retrieved from the CMS. No case was lost to follow up in this study.
In the group of 92 patients, 44 of them were male (47.8%) while the remaining 48 patients were female (52.2%). The mean age of the patients was 75.4 years, ranging from 36 to 104 years.
Out of the 92 patients who survived, 86 were given the discharge diagnosis of CHF by the attending physicians. For the remaining 6 patients with discharge diagnoses other than CHF, the alternative diagnoses were unstable angina (2), chest infection (2), nephrotic syndrome (1), and chronic liver disease (1).
The mean LOS of the patients with BNP level higher and lower than different cut-off points were summarised in Table 1 . It was found that there was a significant difference (P=0.046) in mean LOS between patients with BNP less than 400 pg/ml (93.29 hours, 95%CI 57.38 to 129.19 hours) and patients with BNP greater than 400 pg/ml (181.05 hours, 95%CI 126.01 to 236.08 hours).
In order to assess the accuracy of BNP in identifying patients with LOS less than a certain duration who could be managed in the Short Stay Ward, the receiver operating characteristics (ROC) curves of different cutoff points of BNP level at LOS less than 48 hours, 72 hours and 96 hours were plotted respectively (Tables 2-4). It was found that BNP level less than 400 pg/ml gave the best accuracy in predicting patients with LOS less than 48 hours, giving the area under ROC curve (AUC) equal to 0.732. BNP level less than 300 pg/ml gave the best accuracy in predicting patients with LOS less than 72 hours (AUC=0.651) while BNP level less than 600 pg/ml gave the best accuracy in predicting Tables 5 and 6 respectively. It was found that the cutoff point of BNP level at 600 pg/ml gave the best accuracy in predictive value of readmission and mortality within 6 months. The relative risk of readmission within 6 months was 1.935 (95%CI= 1.154 to 3.236, P=0.012) if the BNP level was greater than 600pg/ml while the relative risk of mortality within 6 months was 9.852 (95%CI=1.352 to 71.776, P=0.024). (Table 7) . These results showed that neither BNP level nor clinical features had good predictive value on LOS. BNP was also not a good predictor in readmission for CHF and mortality.
Multiple regression of LOS versus BNP level and other clinical features was also performed. The coefficient of determination (R 2 ) was 0.2402 and the multiple correlation coefficient was 0.4901. The coefficients and P values of different independent variables were listed in Table 8 . It showed that BNP level correlated poorly with LOS (coefficient=-0.0008, P=0.970) while concomitant medical problems requiring admission (P=0.007) and NYHA functional class (P=0.009) gave significant predictive value on LOS.
Discussion
In general, BNP had a poor correlation with LOS, especially BNP level greater than 800 pg/ml. Other clinical features were also poor predictors of LOS, as Similar situations occurred when BNP was used to predict readmission and mortality within 6 months. BNP gave the best AUC on readmission and mortality when the cut-off point was 600 pg/ml. When predicting readmission, the AUC was only 0.643 with the relative risk of 1.935. This showed the predictive value of BNP on readmission was not very strong. The AUC of the ROC curve on mortality was 0.707 with relative risk of 9.852 (95%CI=1.352 to 71.776). The wide range of 95%CI of relative risk showed the great variability of predictive value of BNP level on mortality. Therefore BNP level should be used with great caution when used to predict mortality. This coincided with similar studies conducted overseas giving the wide variation of CI and wide range of CI of relative risk.
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The poor predictive value of BNP level and other clinical features on LOS illustrates multiple complex factors influencing the LOS of a patient. The complexity of pathophysiology, symptomatology and management of CHF contributes to the variation of LOS. Variation of treatment strategy among different physicians, comorbidities existing before admission and other social factors may also play a role in the variation.
Six out of the 92 patients recruited into this study were given a final diagnosis other than CHF upon discharge. They were not excluded from our study as they presented to the ED with clinical features of CHF initially and were treated as CHF by physicians in the initial phase of hospitalisation. The primary diagnosis was amended after investigation that revealed an alternative diagnosis after admission. However the diagnosis of CHF was still included as a part of secondary diagnosis in these patients. Thus these patients were also included.
Small sample size might also be one of the reasons attributed to the poor predictive value of BNP on LOS in this study. Another reason for the poor predictive value of BNP and clinical features could be attributed to the differences in severity of illness in our patient population as compared to similar studies conducted overseas. In one overseas study, the study population were severely decompensated CHF patients requiring pulmonary artery catheterisation for close monitoring of hemodynamic status 4 whereas the majority of our study subjects were CHF patients with mild to moderate severity. Convenience sampling was also a weakness of this study.
Conclusions
A BNP level less than 400 pg/ml is useful in predicting CHF patients with LOS less than 48 hours. BNP level measured in the emergency department has poor correlation with the LOS of patients presenting with clinical features compatible with CHF. The correlations of BNP level versus readmission and mortality of these patients are also poor. Clinical features are not good predictors for LOS.
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